A perfect storm : the deadly intersection of sickle cell disease and COVID-19

This review critically examines the latest research on the intersection of sickle cell disease (SCD) and COVID-19, highlighting meaningful immunopathological interactions. It reveals significant knowledge gaps, particularly in the analysis of inflammatory markers in clinical studies and the oversigh...

Descripción completa

Detalles Bibliográficos
Autores: Martí-Carvajal, Arturo José, De Sanctis, Juan Bautista
Tipo de recurso: artículo
Fecha de publicación:2025
País:España
Institución:Universidad de Málaga
Repositorio:DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
Idioma:inglés
OAI Identifier:oai:ddfv.ufv.es:10641/6790
Acceso en línea:https://hdl.handle.net/10641/6790
Access Level:acceso abierto
Palabra clave:SARS-CoV-2
cytokine storm
cytokines
inflammation
sickle cell disease
Cytokines
Inflammation
Sickle cell disease
Cytokine storm
Hematology
Oncology
SDG 3 - Good Health and Well-being
Yes
yes
Descripción
Sumario:This review critically examines the latest research on the intersection of sickle cell disease (SCD) and COVID-19, highlighting meaningful immunopathological interactions. It reveals significant knowledge gaps, particularly in the analysis of inflammatory markers in clinical studies and the oversight of SCD in malaria-COVID-19 research conducted in African contexts. The investigation explores shared pathophysiological mechanisms, including the cytokine storm phenomenon, vascular complications, and autoimmune responses, which exemplify the perilous interplay between SCD’s chronic inflammatory state and the acute inflammatory response triggered by COVID-19. Furthermore, it provides a comprehensive analysis of hyperhaemolysis syndrome (HHS), related autoimmune conditions, and avascular necrosis (AVN) as critical complications affecting SCD patients during the COVID-19 pandemic. The aim is to establish a comprehensive framework for understanding this crucial intersection while proposing vital directions for future research and therapeutic interventions.